A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction.
Saved in:
| Title: | A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction. |
|---|---|
| Authors: | Papworth, Monika1 (AUTHOR), Kulkarni, Spoorthy2,3 (AUTHOR), Antonsson, Madeleine4 (AUTHOR), Sermadiras, Isabelle1 (AUTHOR), Hovdal, Daniel4 (AUTHOR), Connolly, Kathleen2 (AUTHOR), Olsson, Jan5 (AUTHOR), Shukla, Animesh6 (AUTHOR), Cotton, Peter7 (AUTHOR), Althage, Magnus4 (AUTHOR), Paterson, Judy1 (AUTHOR), Martin, Esther1 (AUTHOR), Wolny, Marcin1 (AUTHOR), Ferraro, Franco1 (AUTHOR), Sadowska, Agnieszka8 (AUTHOR), Hao, Weidong8 (AUTHOR), Larsson, Niklas9 (AUTHOR), Backmark, Anna4 (AUTHOR), Marlow, Tom10 (AUTHOR), Perez, Rosario11 (AUTHOR) |
| Source: | Cardiovascular Research. May2025, Vol. 121 Issue 6, p871-881. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
